nifekalant hydrochloride has been researched along with disopyramide in 2 studies
| Studies (nifekalant hydrochloride) | Trials (nifekalant hydrochloride) | Recent Studies (post-2010) (nifekalant hydrochloride) | Studies (disopyramide) | Trials (disopyramide) | Recent Studies (post-2010) (disopyramide) |
|---|---|---|---|---|---|
| 138 | 16 | 38 | 1,659 | 206 | 64 |
| Protein | Taxonomy | nifekalant hydrochloride (IC50) | disopyramide (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 2.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aikawa, M; Handa, S; Iwamoto, T; Iwata, O; Kusuzaki, S; Mori, H; Shinozaki, Y; Tanabe, T | 1 |
| Enjoji, Y; Funatsu, A; Kambayashi, D; Kobayashi, T; Mizobuchi, M; Nakamura, S; Ono, T; Yamamoto, R | 1 |
2 other study(ies) available for nifekalant hydrochloride and disopyramide
| Article | Year |
|---|---|
Electrophysiologic and blood-flow responses in the endocardium and epicardium to disopyramide and MS-551 during myocardial ischemia in the dog.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Coronary Circulation; Disopyramide; Dogs; Endocardium; Myocardial Ischemia; Pericardium; Pyrimidinones; Refractory Period, Electrophysiological | 1999 |
Nifekalant and disopyramide in a patient with short QT syndrome: evaluation of pharmacological effects and electrophysiological properties.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Body Surface Potential Mapping; Disopyramide; Humans; Male; Pyrimidinones; Syndrome; Tachycardia, Ventricular; Treatment Outcome; Young Adult | 2008 |